Brief: Shilpa Medicare Gets Europe Approval For Tadalafil Orodisperible Films
10/01/2025 10:34
Jan 10 (Reuters) - Shilpa Medicare Ltd SHME.NS :
* GETS EUROPE APPROVAL FOR TADALAFIL ORODISPERIBLE FILMS
Source text: ID:nBSEc1X0WN
Further company coverage: SHME.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026